Author details

Full Name

Jerry Usary

Affiliation

ORCID

Career Start Year

2001

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
30484104	A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer.	Breast Cancer Research and Treatment	2019
29254140	Differential response to exercise in claudin-low breast cancer.	Oncotarget	2017
28348404	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.	Nat Commun	2017
28748213	Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer.	NPJ Breast Cancer	2017
28440318	Corrigendum: Proteogenomic integration reveals therapeutic targets in breast cancer xenografts.	Nat Commun	2017
29657983	Discrete microfluidics for the isolation of circulating tumor cell subpopulations targeting fibroblast activation protein alpha and epithelial cell adhesion molecule.	NPJ Precis Oncol	2017
26995547	Overview of Genetically Engineered Mouse Models of Distinct Breast Cancer Subtypes.	Current Protocols in Pharmacology	2016
24056965	c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer.	Oncogene	2014
23780888	Predicting drug responsiveness in human cancers using genetically engineered mice.	Clin Cancer Res	2013
24220145	Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts.	Genome Biol	2013
21633010	Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.	Proceedings of the National Academy of Sciences of the United States of America	2012
22588949	Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models.	Cancer Prevention Research	2012
22302033	Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.	J Natl Cancer Inst	2012
22500798	Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer.	Cell	2012
22624713	Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer.	Cancer Cell	2012
22872574	Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models.	Clin Cancer Res	2012
23486760	Targeting the PyMT Oncogene to Diverse Mammary Cell Populations Enhances Tumor Heterogeneity and Generates Rare Breast Cancer Subtypes.	Genes and Cancer	2012
21673995	The role of calcineurin/NFAT in SFRP2 induced angiogenesis--a rationale for breast cancer treatment with the calcineurin inhibitor tacrolimus.	PLoS ONE	2011
19411068	CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.	Cancer Cell	2009
17493263	Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.	Genome Biol	2007
16505416	Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.	Journal of Clinical Oncology	2006
15113400	Universal Reference RNA as a standard for microarray experiments.	BMC Genomics	2004
15361840	Mutation of GATA3 in human breast tumors.	Oncogene	2004
11401702	Erythromycin inhibition of 50S ribosomal subunit formation in Escherichia coli cells.	Molecular Microbiology	2001